|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| REVENUES | ||||
| OPERATING EXPENSES: | ||||
| Research and development | ||||
| Selling, general and administrative | ||||
| Impairment loss | ||||
| Total Operating Expenses | ||||
| LOSS FROM OPERATIONS | ||||
| Interest income | ||||
| Realized gain on short-term investments | ||||
| Total other income | ||||
| OTHER INCOME (LOSS): | ||||
| Interest income | ||||
| Unrealized gain on short-term investments | ||||
| Realized gain on short-term investments | ||||
| Realized loss on exchange of equity securities | ||||
| Total other income, net | ||||
| NET LOSS | ||||
| Other comprehensive income: | ||||
| Unrealized gain (loss) on short-term debt investments | ||||
| Comprehensive loss | ||||
| NET LOSS PER COMMON SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS: | ||||
| Basic (in Dollars per share) | ||||
| Diluted (in Dollars per share) | ||||
| WEIGHTED AVERAGE COMMON SHARE OUTSTANDING: | ||||
| Basic (in Shares) | ||||
| Diluted (in Shares) | ||||
| Net loss of subsidiary attributable to noncontrolling interest | ||||
| NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS |
Loading...